Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D known ✓ | P28221 | 3/20 | 0.51 |
| ▸ | ACHE known ✓ | P22303 | 2/20 | 0.49 |
| ▸ | HTR1B known ✓ | P28222 | 1/20 | 0.45 |
| ▸ | DRD2 | P14416 | 12/20 | 0.70 |
| ▸ | DRD3 | P35462 | 11/20 | 0.70 |
| ▸ | DRD4 | P21917 | 5/20 | 0.70 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.54 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.54 |
| ▸ | CA1 | P00915 | 2/20 | 0.49 |
| ▸ | CA2 | P00918 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2486274 | 0.99 | DRD2 (0.72) | DRD2DRD3DRD4MTNR1AMTNR1B | |
| SCHEMBL7899018 | 0.99 | DRD2 (0.72) | DRD2DRD3DRD4MTNR1AMTNR1B | |
| SCHEMBL17446303 | 0.84 | DRD2 (0.64) | DRD2DRD3DRD4MTNR1AMTNR1B | |
| SCHEMBL17446276 | 0.84 | DRD2 (0.64) | DRD2DRD3DRD4MTNR1AMTNR1B | |
| SCHEMBL17446277 | 0.84 | DRD2 (0.64) | DRD2DRD3DRD4MTNR1AMTNR1B | |
| SCHEMBL23174509 | 0.84 | DRD2 (0.64) | DRD2DRD3DRD4MTNR1AMTNR1B | |
| SCHEMBL17446278 | 0.84 | DRD2 (0.64) | DRD2DRD3DRD4MTNR1AMTNR1B | |
| SCHEMBL23174465 | 0.84 | DRD2 (0.64) | DRD2DRD3DRD4MTNR1AMTNR1B | |
| SCHEMBL17446304 | 0.84 | DRD2 (0.64) | DRD2DRD3DRD4MTNR1AMTNR1B | |
| SCHEMBL7454456 | 0.83 | DRD2 (1.00) | DRD2DRD3DRD4MTNR1AMTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8513438-B2 | Process for the preparation of (6S)-(-)-5,6,7,8-tetrahydro-6-[propyl-(2-thienyl)ethyl]amino-1-naphthol (Rotigotine) | INTERQUIM, S.A. (ES) | 2013-08-20 | — | — | US | disclosed |
| EP-2376470-B1 | PROCESS FOR THE PREPARATION OF (6S)-(-)-5,6,7,8-TETRAHYDRO-6-[PROPYL-(2-THIENYL)ETHYL]AMINO-1-NAPHTHOL (ROTIGOTINE) | INTERQUIM SA (ES) | 2013-04-10 | — | — | EP | disclosed |
| US-20110306776-A1 | PROCESS FOR THE PREPARATION OF (6S)-(-)-5,6,7,8-TETRAHYDRO-6-[PROPYL-(2-THIENYL)ETHYL]AMINO-1-NAPHTHOL (ROTIGOTINE) | INTERQUIM, S.A. (ES) | 2011-12-15 | — | — | US | disclosed |
| EP-2376470-A1 | PROCESS FOR THE PREPARATION OF (6S)-(-)-5,6,7,8-TETRAHYDRO-6-ÝPROPYL-(2-THIENYL)ETHYL¨AMINO-1-NAPHTHOL (ROTIGOTINE) | Interquim, S.A (ES) | 2011-10-19 | — | — | EP | disclosed |
| WO-2010066755-A1 | PROCESS FOR THE PREPARATION OF (6S)-(-)-5,6,7,8-TETRAHYDRO-6-[PROPYL-(2-THIENYL)ETHYL]AMINO-1-NAPHTHOL (ROTIGOTINE) | INTERQUIM, S.A. (ES) | 2010-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110306776-A1 | PROCESS FOR THE PREPARATION OF (6S)-(-)-5,6,7,8-TETRAHYDRO-6-[PROPYL-(2-THIENYL)ETHYL]AMINO-1-NAPHTHOL (ROTIGOTINE) | NAT1, COMT, PARK7 | HTR1D 712/4885ACHE 194/4885HTR1B 726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.